Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2009.24.9557 on February 16 2010

Journal of Clinical Oncology, Vol 28, No 9 (March 20), 2010: pp. 1458-1466
© 2010 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Friedenreich, C. M.
Right arrow Articles by Courneya, K. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedenreich, C. M.
Right arrow Articles by Courneya, K. S.
Related Articles
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Alberta Physical Activity and Breast Cancer Prevention Trial: Sex Hormone Changes in a Year-Long Exercise Intervention Among Postmenopausal Women

Christine M. Friedenreich, Christy G. Woolcott, Anne McTiernan, Rachel Ballard-Barbash, Rollin F. Brant, Frank Z. Stanczyk, Tim Terry, Norman F. Boyd, Martin J. Yaffe, Melinda L. Irwin, Charlotte A. Jones, Yutaka Yasui, Kristin L. Campbell, Margaret L. McNeely, Kristina H. Karvinen, Qinggang Wang, Kerry S. Courneya

From Alberta Health Services; Department of Medicine, University of Calgary, Calgary; Cross Cancer Institute, Alberta Health Services; Departments of Public Health Sciences, Physical Therapy, and Oncology and Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta; Departments of Statistics and Physical Therapy, University of British Columbia, Vancouver, British Columbia; Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute; Sunnybrook Research Institute, Toronto, Ontario, Canada; Cancer Research Center of Hawai'i, University of Hawai'i, Honolulu, HI; Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; School of Medicine, University of Southern California, Los Angeles, CA; Department of Epidemiology and Public Health, Yale University, New Haven, CT; and Department of Exercise and Sports Science, East Carolina University, Greenville, NC.

Corresponding author: Christine M. Friedenreich, PhD, Alberta Health Services, Calgary, Alberta, Canada, T2N 4N2; e-mail: christine.friedenreich{at}albertahealthservices.ca.

Purpose We examined how an aerobic exercise intervention influenced circulating estradiol, estrone, sex hormone–binding globulin (SHBG), androstenedione, and testosterone levels, which may be involved in the association between physical activity and breast cancer risk.

Methods A two-center, two-arm randomized controlled trial of exercise was conducted in 320 postmenopausal, sedentary women age 50 to 74 years. Participants were randomly assigned to a 1-year aerobic exercise intervention of 225 min/wk (n = 160) or to a control group who maintained their usual level of activity (n = 160). Baseline, 6-month, and 12-month assessments of estrone, estradiol, androstenedione, and testosterone were quantified by radioimmunoassay after extraction, and SHBG was quantified by an immunometric assay. Intent-to-treat analyses were performed using linear mixed models.

Results Blood data were available on 309 women (96.6%) at 12 months. Women in the intervention group exercised an average of 3.6 d/wk for 178 min/wk. At 12 months, statistically significant reductions in estradiol (treatment effect ratio [TER] = 0.93; 95% CI, 0.88 to 0.98) and free estradiol (TER = 0.91; 95% CI, 0.87 to 0.96) and increases in SHBG (TER = 1.04; 95% CI, 1.02 to 1.07) were observed in the exercise group compared with the control group. No significant differences in estrone, androstenedione, and testosterone levels were observed between exercisers and controls at 12 months.

Conclusion This trial found that previously sedentary postmenopausal women can adhere to a moderate- to vigorous-intensity exercise program that results in changes in estradiol and SHBG concentrations that are consistent with a lower risk for postmenopausal breast cancer.

See accompanying editorial on page 1445

Supported by Research Grant No. 017468 from the Canadian Breast Cancer Research Alliance. C.M.F. is supported by career awards from the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research. K.S.C. is supported by the Canada Research Chairs Program.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Clinical trial information can be found for the following: NCT00522262 [ClinicalTrials.gov] .


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

  • Lifestyle and Breast Cancer Risk: The Way Forward?
    Rowan T. Chlebowski
    JCO 2010 28: 1445-1447 [Full Text]


This article has been cited by other articles:


Home page
JCOHome page
R. T. Chlebowski
Lifestyle and Breast Cancer Risk: The Way Forward?
J. Clin. Oncol., March 20, 2010; 28(9): 1445 - 1447.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2010 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online